Orforglipron: Phase 3 trial results are expected in 2025
Somatostatin, the hormone that normally inhibits growth hormone release, continues functioning properly, maintaining physiological balance
Where PlexusDx pricing sits, stated plainly Rather than surface a number only after intake, PlexusDx lists its weight-management pricing up front
Foods such as chips, pastries, full-fat takeaways, and heavily buttered dishes slow gastric emptying even further, compounding the drug's existing effect and increasing the risk of nausea, vomiting, and upper abdominal discomfort
To date, clinical data have been reported for two dual GIP/GLP-1 receptor agonists
When planning meals, keep these key things in mind: protein, nutrients, and balance